Skip to main content

Lupkynis News

Voclosporin Safe, Effective for Long-Term Treatment of Lupus Nephritis

WEDNESDAY, July 26, 2023 – Voclosporin can preserve kidney function up to three years for patients with lupus nephritis, according to a study published online July 19 in Arthritis & Rheumatology....

FDA Approves Lupkynis (voclosporin) for Adult Patients with Active Lupus Nephritis

VICTORIA, British Columbia & ROCKVILLE, Md.-- January 22, 2021 – Aurinia Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Lupkynis (voclosporin) in...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Lupkynis patient information at Drugs.com